Concepedia
Statistics
Publications
6
Citations
201
H-Index
Active since
1993
Affiliations
University of Kentucky(Current)
The Graduate Center, CUNY
A M Fredenburg is an author at University of Kentucky specializing in pharmacology, bioavailability, and chelation therapy.
Publications per year
1993–2000
The pharmacokinetics and blood-brain barrier permeation of the chelators 1,2 dimethyl-, 1,2 diethyl-, and 1-[ethan-1′ ol]-2-methyl-3-hydroxypyridin-4-one in the rat
A M Fredenburg, Rajiv K. Sethi, David D. Allen et al. · Toxicology · 1996 · 93 citations
Pharmacy, Pharmacokinetics, Pharmacology +13
The Hexadentate Hydroxypyridinonate TREN‐(Me‐3,2‐HOPO) is a More Orally Active Iron Chelator Than Its Bidentate Analogue
Robert A. Yokel, A M Fredenburg, Patricia W. Durbin et al. · Journal of Pharmaceutical Sciences · 2000 · 39 citations
Medicine, Medicinal Chemistry, Pharmacology +11
The 3-hydroxypyridin-4-ones more effectively chelate aluminum in a rabbit model of aluminum intoxication than does desferrioxamine.
Robert A. Yokel, K A Meurer, Thomas L. Skinner et al. · Drug Metabolism and Disposition · 1996 · 28 citations
Veterinary Medicine, Pharmacology, Toxicology +17
Influence of lipophilicity on the bioavailability and disposition of orally active 3-hydroxypyridin-4-one metal chelators.
Robert A. Yokel, A M Fredenburg, K A Meurer et al. · Drug Metabolism and Disposition · 1995 · 20 citations
Pharmacy, Pharmacokinetics, Pharmacology +10
Pharmacokinetics of representative 3-hydroxypyridin-4-ones in rabbits: CP20 and CP94.
A M Fredenburg, P J Wedlund, Thomas L. Skinner et al. · Drug Metabolism and Disposition · 1993 · 11 citations
Pharmacy, Pharmacokinetics, Pharmacology +14
1–5 of 6